drugset / Trial / NCT00294619

Treatment of Adults With Growth Hormone Deficiency

NCT00294619 ↗

Phase 3 Completed 147 enrolled LG Life Sciences BioPartners GmbH · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate efficacy and safety profile of a new weekly administered growth hormone preparation compared with placebo in adults with growth hormone deficiency.

Timeline

Start
2006-04
Primary completion
2008-03
Completion
2008-03

Drugs

EvaluationDrugModalityDoseRoute
Subject LB03002 Protein / enzyme biologic — Subcutaneous